Last update:

Oncology & Cancer news

Oncology & Cancer

Sugary drinks may increase risk of metastasis in advanced colorectal cancer

A new study from researchers at The University of Texas MD Anderson Cancer Center shows that the glucose-fructose mix found in sugary drinks directly fuels metastasis in preclinical models of advanced colorectal cancer. The ...

Oncology & Cancer

Gut bacterial adhesion mechanism revealed as target for novel colorectal cancer therapies

Fusobacterium nucleatum (F. nucleatum) is an anaerobic bacterium notably enriched in the gut microbiota of colorectal cancer (CRC) patients and may play a role in CRC both by colonizing tumor cells and suppressing immune ...

Oncology & Cancer

Young adult cancer survivors may face elevated social risks

Young adult survivors of cancer aged 18 to 39 faced elevated social risks compared with their peers who did not have cancer histories and survivors from older age cohorts, according to a study presented at the 18th AACR Conference ...

Oncology & Cancer

Obesity-associated cancers may be on the rise in Puerto Rico

The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...

Oncology & Cancer

Dietary supplement found effective for skin cancer prevention

The dietary supplement nicotinamide has been recommended by dermatologists for people with a history of skin cancer since 2015, when a clinical study with 386 participants showed that those who took the vitamin B3 derivative ...

Oncology & Cancer

Certain oral microbes tied to increased risk of pancreatic cancer

Twenty-seven species of bacteria and fungi among the hundreds that live in people's mouths have been collectively tied to a 3.5 times greater risk of developing pancreatic cancer, a study led by NYU Langone Health and its ...

Oncology & Cancer

Digital cell twin opens up new avenues in lung cancer research

A team led by Christian Baumgartner of the Institute of Health Care Engineering at Graz University of Technology (TU Graz) has developed a highly detailed digital twin of the A549 lung cancer cell line. The twin builds on ...

Oncology & Cancer

Lymph nodes found to be key to successful cancer immunotherapy

A team of researchers, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute), explored the cellular and molecular interactions revealing how lymph nodes play a crucial role in the fight against ...

Oncology & Cancer

Genomic score predicts patients' progression to multiple myeloma

A new risk assessment score developed by researchers at Dana-Farber Cancer Institute, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital reveals how multiple myeloma, a form of blood cancer, begins ...

Oncology & Cancer

Beyond tired with cancer-related fatigue

Cancer-related fatigue can be distressing. It is a persistent, subjective sense of physical, emotional and cognitive tiredness and/or exhaustion related to cancer or cancer treatment that is not proportional to recent activity. ...

Oncology & Cancer

Genetic test can diagnose brain tumors in as little as two hours

Scientists and medics have developed an ultra-rapid method of genetically diagnosing brain tumors that will cut the time it takes to classify them from six to eight weeks, to as little as two hours—which could improve care ...

Oncology & Cancer

'Obesity paradox' extends to cancer treatment, study finds

It's well-known that obesity is a risk factor for cardiovascular disease. But some research suggests that while people who are obese are more likely to develop cardiovascular problems, they're also less likely to die from ...

Oncology & Cancer

Deep learning can predict lung cancer risk from single LDCT scan

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference, and in American Journal of Respiratory ...